| Novartis Pharma Schweiz AG - Lamisil 250 mg, Tabletten |
| 51306 | | 02 | | Lamisil 250 mg | | Tabletten | | D01BA02 | | Terbinafine | | 27.08.1991 | | |
|
| Composition |
| terbinafinum 250 mg ut terbinafini hydrochloridum, magnesii stearas, hypromellosum, silica colloidalis anhydrica, carboxymethylamylum natricum A corresp. natrium max. 1.9 mg, cellulosum microcristallinum pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Terbinafine | 250 mg |
| | BAG: Active Agent | Dose |
|---|
| Terbinafine | 250 mg |
| | | | Inactive agents |
|---|
| Carboxymethylamylum Natricum A | | Cellulosum Microcristallinum pro Compresso | | Hypromellosum | | Magnesii Stearas | | Silica Colloidalis Anhydrica |
| |
|
|
